Drawing for MBL

USPTO serial 97622009

MBL

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
GOODWIN, KATRINA JOYE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with MBL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $498*

Plus Government fees of $250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES J. BOSCO, JR.

JAMES J. BOSCO, JR. THE WEBB LAW FIRMONE GATEWAY CENTER420 FORT DUQUESNE BOULEVARD, SUITE 1200PITTSBURGH, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immunological disorders, respiratory diseases, apoptosis, signal transduction, DNA, proteomics and genomics; Reagents for use in medical genetic testing; Immunoassay reagents for medical use; Diagnostic biomarker reagents for medical purposes; Companion diagnostics, namely, medical diagnostic reagents that assist in predicting the effects of a drug, the presence or absence of side effects, and the choice of patients to administerACTIVE—
042Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research purposes, for others; Stem cell research services; Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals, in vitro diagnostics, treatment or diagnostics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development support services, namely, pharmaceutical research and development; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 12, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 29, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 29, 2025ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Dec 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 6, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 6, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 7, 2025EXPTEXPARTE APPEAL TERMINATED—
Apr 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 24, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 24, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Sep 24, 2024CNSLSUSPENSION LETTER WRITTEN—
Jul 12, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 12, 2024EXPIEX PARTE APPEAL-INSTITUTED—
Jul 12, 2024JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jul 12, 2024EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Apr 12, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 12, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 20, 2024DOCKASSIGNED TO EXAMINER—
Jan 12, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 12, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 12, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2023DOCKASSIGNED TO EXAMINER—
Oct 23, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance